Does Ultralife Corporation (ULBI) Have Momentum?
With data as of October 28, 2026, we examine if Ultralife Corporation(ULBI) is consistently building momentum based on AAII's A+ Investor Momentum and Value Scores and Grades.Michael Rose
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Michael Rose
Michael Rose
Michael Rose
Cynthia McLaughlin
Rosalio Madrigal
| Share Statistics | ULBI | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $260.3 | $597.4 | 31% |
|
| Shares Out (Mil) | 16.7 | 51.4 | 28% |
|
| Institutional Ownership | 43.4% | 66.9% | 18% |
|
| Float (Mil) | 9.6 | 47.2 | 19% |
|
| Beta | 0.83 | 1.23 | 49% |
|
| Avg Daily Volume (000s) | 434 | 346 | 57% |
|
| Price Change (52-week) |
127.7% | 41.5% | 97% |
|
| Growth | ULBI | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 12.2% | 9.4% | 66% |
|
| Net Income (5yr) | (25.7%) | (2.5%) | 16% |
|
| EPS (5yr) | (25.2%) | 6.9% | 11 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (5.6%) | (14.8%) | 60% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | ULBI | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $187 | $377 | 31% |
|
| Net Income (TTM) (Mil) | ($7) | ($2) | 32% |
|
| EPS (TTM) | ($0.393) | ($0.200) | 29% |
|
| Operating Cash Flow (TTM) (Mil) | $5 | ($3) | 36% |
|
| Net Cash Flow (TTM) (Mil) | ($4) | $11 | 35% |
|
| Long-Term Debt (Q1) (Mil) | $45 | $41 | 38% |
|
| Enterprise Value (Q1) (Mil) | $134 | $836 | 23% |
|
| Valuation | ULBI | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.96 | 2.19 | 53% |
|
| P/E | na | 29.5 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.0 | na |
|
| Ratios | ULBI | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 24.4% | 27.8% | 27% |
|
| Net Margin | (3.5%) | 1.0% | 27% |
|
| ROA | (3.0%) | (2.9%) | 32% |
|
| ROE | (4.8%) | 7.2% | 31% |
|
| Liabilities to Assets | 38.7% | 55.9% | 29% |
|
| F-Score | 3 | 4 | 18% |
|
Ultralife Corporation did not pass any screens on 11/2/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors